Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

31.160
+0.9603.18%
Volume:33.90K
Turnover:1.04M
Market Cap:4.18B
PE:-28.07
High:31.500
Open:30.500
Low:29.500
Close:30.200
52wk High:33.800
52wk Low:13.480
Shares:134.00M
HK Float Shares:134.00M
Volume Ratio:1.55
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.110
ROE:-27.27%
ROA:-12.63%
PB:5.13
PE(LYR):-28.07
PS:38894.25

Loading ...

Hanx Biopharmaceuticals files HKEX next-day disclosure return on share buyback cancellation

Reuters
·
Jun 09

HANXBIO-B Allocates HK$1.6785 Million for Share Buyback on June 8

Stock News
·
Jun 08

Hanx Bio repurchases 0.04 million H shares at up to HKD 27.98, expands treasury stock to 1.04 million

Bulletin Express
·
Jun 05

HANXBIO-B buys back 27,700 H shares for HK$0.77 million, lifting treasury stock to over 1 million shares

Bulletin Express
·
Jun 04

HANXBIO-B Executes Share Buyback, Spending HK$765,400

Stock News
·
Jun 04

Hanx Biopharma files HKEX next-day return disclosing share buyback at HKD 27.63 each

Reuters
·
Jun 04

HANXBIO-B repurchases 53,100 H-shares for HKD 1.44 million, cutting free float by 0.04%

Bulletin Express
·
Jun 03

HANXBIO-B Executes Share Buyback Valued at Approximately HK$1.44 Million

Stock News
·
Jun 03

HANXBIO-B buys back 405,800 H-shares in May, spending HKD 12.08 million while maintaining public float

Bulletin Express
·
Jun 03

Hanx Biopharmaceuticals repurchases HKD 1.07 million of H-shares; treasury stock climbs to 0.68 % of total issued capital

Bulletin Express
·
Jun 02

Hanx Biopharmaceuticals Calls 24 Jun 2026 AGM to Vote on 2025 Results, 20% Issuance Mandate and 10% H-Share Buyback

Bulletin Express
·
Jun 02

Hanx Biopharmaceuticals to Seek 20% Issuance, 10% Buy-back Mandates and Expand Business Scope

Bulletin Express
·
Jun 02

Hanx Biopharmaceuticals Relocates Hong Kong Principal Office to Lee Garden One

Bulletin Express
·
Jun 02

Hanx Biopharmaceuticals relocates Hong Kong principal office to Lee Garden One, Causeway Bay

Reuters
·
Jun 02

HANXBIO-B Spends HK$517,600 on Share Buyback

Stock News
·
Jun 01

HANXBIO-B (03378) Spends HK$477,500 on Share Buyback on May 29

Stock News
·
May 29

HANXBIO-B repurchases 18,100 H shares, expanding treasury stock to 847,800 units

Bulletin Express
·
May 28

HANXBIO-B Executes Share Buyback Worth Approximately HK$494,100 on May 28

Stock News
·
May 28

Hanx Biopharma files HKEX next-day return disclosing share buyback at HKD 27.3 each

Reuters
·
May 28

HANXBIO-B repurchases 22,400 H shares, treasury stock rises to 0.61% of mandate

Bulletin Express
·
May 27